What are the most common immunodeficiencies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Primary Immunodeficiencies

Selective IgA deficiency is the most common primary immunodeficiency, occurring in 1 in 300-700 live births among white Americans, followed by antibody deficiencies which collectively account for approximately 50% of all primary immunodeficiency disorders. 1

Frequency Hierarchy of Primary Immunodeficiencies

Most Common: Selective IgA Deficiency (SIgAD)

  • Incidence: 1 in 300-700 live births in white Americans (though significantly rarer in Asian populations at approximately 1 in 18,000) 1, 2
  • Most patients (>50%) remain asymptomatic despite the immunologic defect 2
  • Defined as IgA levels <7 mg/dL with normal IgG and IgM levels 2
  • Can be drug-induced and potentially reversible with medication cessation 2

Second Most Common Category: Antibody/Humoral Deficiencies

  • Account for approximately 50% of all symptomatic primary immunodeficiency disorders 1
  • This broad category includes:
    • Common Variable Immunodeficiency (CVID): Most common symptomatic antibody deficiency requiring treatment 3, 4
    • IgG subclass deficiency 1
    • Specific antibody deficiency 1
    • Transient hypogammaglobulinemia of infancy 3
    • X-linked agammaglobulinemia (Bruton agammaglobulinemia): accounts for 85% of agammaglobulinemia cases 1

Less Common Categories (Each 10-20% of Total)

  • Combined B- and T-cell defects: 10-20% of all primary immunodeficiencies 1
    • Severe Combined Immunodeficiency (SCID): approximately 1 in 58,000 live births in the United States 1
  • Phagocyte defects: 10-20% of all primary immunodeficiencies 1
    • Chronic Granulomatous Disease (CGD): 1 in 200,000 live births 1
  • Other syndromes: 10-20% of all primary immunodeficiencies, including Wiskott-Aldrich syndrome, DiGeorge syndrome, ataxia-telangiectasia, and hyper-IgE syndromes 1

Rare Categories (Each <1% of Total)

  • Diseases of immune dysregulation 1
  • Disorders of innate immunity (including NK cell defects) 1
  • Autoinflammatory disorders 1
  • Complement deficiencies 1

Overall Prevalence Context

  • All symptomatic primary immunodeficiencies combined: incidence ranges from 1 in 10,000 to 1 in 2,000 live births 1
  • Prevalence in general population: 1 in 10,000 to 1 in 12,000 or more 1
  • Male to female ratio is approximately 5:1 in infants and children but approaches 1:1 in adults 1

Critical Clinical Pitfall

Do not dismiss selective IgA deficiency as clinically insignificant simply because most patients are asymptomatic - selected patients suffer from serious complications including recurrent pulmonary infections, autoimmune diseases, gastrointestinal disorders, and malignancy 5. Additionally, some patients with SIgAD can evolve to CVID over time, necessitating long-term monitoring 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pathogenesis and Clinical Characteristics of Selective IgA Deficiency (SIgAD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical and experimental treatment of primary humoral immunodeficiencies.

Clinical and experimental immunology, 2024

Research

Common Variable Immunodeficiency.

The Medical clinics of North America, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.